18F-FDG brain PET hypometabolism in post-SARS-CoV-2 infection: substrate for persistent/delayed disorders?
- PMID: 32728799
- PMCID: PMC7391029
- DOI: 10.1007/s00259-020-04973-x
18F-FDG brain PET hypometabolism in post-SARS-CoV-2 infection: substrate for persistent/delayed disorders?
Abstract
Purpose: Several brain complications of SARS-CoV-2 infection have been reported. It has been moreover speculated that this neurotropism could potentially cause a delayed outbreak of neuropsychiatric and neurodegenerative diseases of neuroinflammatory origin. A propagation mechanism has been proposed across the cribriform plate of the ethmoid bone, from the nose to the olfactory epithelium, and possibly afterward to other limbic structures, and deeper parts of the brain including the brainstem.
Methods: Review of clinical examination, and whole-brain voxel-based analysis of 18F-FDG PET metabolism in comparison with healthy subjects (p voxel < 0.001, p-cluster < 0.05, uncorrected), of two patients with confirmed diagnosis of SARS-CoV-2 explored at the post-viral stage of the disease.
Results: Hypometabolism of the olfactory/rectus gyrus was found on the two patients, especially one with 4-week prolonged anosmia. Additional hypometabolisms were found within amygdala, hippocampus, parahippocampus, cingulate cortex, pre-/post-central gyrus, thalamus/hypothalamus, cerebellum, pons, and medulla in the other patient who complained of delayed onset of a painful syndrome.
Conclusion: These preliminary findings reinforce the hypotheses of SARS-CoV-2 neurotropism through the olfactory bulb and the possible extension of this impairment to other brain structures. 18F-FDG PET hypometabolism could constitute a cerebral quantitative biomarker of this involvement. Post-viral cohort studies are required to specify the exact relationship between such hypometabolisms and the possible persistent disorders, especially involving cognitive or emotion disturbances, residual respiratory symptoms, or painful complaints.
Keywords: 18F-FDG-PET; Anosmia; Brainstem; COVID-19; Functional disorders; Limbic system; SARS-CoV-2.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Figures


Similar articles
-
18F-FDG brain PET hypometabolism in patients with long COVID.Eur J Nucl Med Mol Imaging. 2021 Aug;48(9):2823-2833. doi: 10.1007/s00259-021-05215-4. Epub 2021 Jan 26. Eur J Nucl Med Mol Imaging. 2021. PMID: 33501506 Free PMC article.
-
Persistent brain metabolic impairment in long COVID patients with persistent clinical symptoms: a nine-month follow-up [18F]FDG-PET study.Eur J Nucl Med Mol Imaging. 2024 Sep;51(11):3215-3222. doi: 10.1007/s00259-024-06775-x. Epub 2024 Jun 12. Eur J Nucl Med Mol Imaging. 2024. PMID: 38862619
-
Long COVID hallmarks on [18F]FDG-PET/CT: a case-control study.Eur J Nucl Med Mol Imaging. 2021 Sep;48(10):3187-3197. doi: 10.1007/s00259-021-05294-3. Epub 2021 Mar 7. Eur J Nucl Med Mol Imaging. 2021. PMID: 33677642 Free PMC article.
-
18F-FDG-PET Imaging for Post-COVID-19 Brain and Skeletal Muscle Alterations.Viruses. 2021 Nov 15;13(11):2283. doi: 10.3390/v13112283. Viruses. 2021. PMID: 34835088 Free PMC article. Review.
-
18F-FDG-PET/CT in SARS-CoV-2 infection and its sequelae.Rev Esp Med Nucl Imagen Mol (Engl Ed). 2021 Sep-Oct;40(5):299-309. doi: 10.1016/j.remnie.2021.07.005. Epub 2021 Jul 28. Rev Esp Med Nucl Imagen Mol (Engl Ed). 2021. PMID: 34340958 Free PMC article. Review.
Cited by
-
A Prospect to Ameliorate Affective Symptoms and to Enhance Cognition in Long COVID Using Auricular Transcutaneous Vagus Nerve Stimulation.J Clin Med. 2023 Feb 2;12(3):1198. doi: 10.3390/jcm12031198. J Clin Med. 2023. PMID: 36769845 Free PMC article.
-
The Combined Use of Neuropsychiatric and Neuropsychological Assessment Tools to Make a Differential Dementia Diagnosis in the Presence of "Long-Haul" COVID-19.Case Rep Neurol. 2022 Mar 15;14(1):130-148. doi: 10.1159/000522020. eCollection 2022 Jan-Apr. Case Rep Neurol. 2022. PMID: 35431881 Free PMC article.
-
Brain fog as a Long-term Sequela of COVID-19.SN Compr Clin Med. 2023;5(1):9. doi: 10.1007/s42399-022-01352-5. Epub 2022 Nov 24. SN Compr Clin Med. 2023. PMID: 36466122 Free PMC article. Review.
-
Olfactory and gustatory disorders in COVID-19.Allergo J Int. 2022;31(7):243-250. doi: 10.1007/s40629-022-00216-7. Epub 2022 Jun 20. Allergo J Int. 2022. PMID: 35755859 Free PMC article. Review.
-
Cognitive phenotyping of post-infectious SARS-CoV-2 patients.Neurol Sci. 2022 Aug;43(8):4599-4604. doi: 10.1007/s10072-022-06130-8. Epub 2022 May 23. Neurol Sci. 2022. PMID: 35604618 Free PMC article.
References
-
- Serrano-Castro PJ, Estivill-Torrús G, Cabezudo-García P, Reyes-Bueno JA, Ciano Petersen N, Aguilar-Castillo MJ, et al. Impact of SARS-CoV-2 infection on neurodegenerative and neuropsychiatric diseases: a delayed pandemic? Neurologia. 2020;35:245–251. doi: 10.1016/j.nrl.2020.04.002. - DOI - PMC - PubMed
-
- Rogers JP, Chesney E, Oliver D, Pollak TA, McGuire P, Fusar-Poli P, et al. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry. 2020. 10.1016/S2215-0366(20)30203-0. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous